Kaken Pharmaceutical Co Limited

Download PDF
Email profile changes
Upgrade this profile
Add a new company

Members:
Ammend this profile
Login

Contact Details: 1 Hinode Urayasu-shi Chiba 279 Japan Tel: 81 0 473 90 6111 Fax: 00 81 0 473 90 6156 Email:

Recent Publications by Kaken Pharmaceutical Co Limited:
Effects of KP-496, a novel dual antagonist at the cysteinyl leukotriene receptor 1 and the thromboxane A(2) receptor, on airway obstruction in guinea pigs. BACKGROUND AND PURPOSE: KP-496 is a novel dual antagonist for cysteinyl...	15th May, 2008	Pharmacology Department, Central Research Laboratories, Kaken	Br J Pharmacol. 2008 Feb;153(4):669-75. Epub 2007 Nov 26. DOI Direct Link
Preparation of rapidly disintegrating tablets containing itraconazole solid dispersions. The disintegratability of tablets prepared from two types of solid...	6th February, 2008	Drug Formulation Department, Central Research Laboratories, Kaken	Chem Pharm Bull (Tokyo). 2007 Nov;55(11):1557-62.
Fibroblast growth factor-2-induced host stroma reaction during initial tumor growth promotes progression of mouse melanoma via vascular endothelial growth factor A-dependent neovascularization. Fibroblast growth factor (FGF)-2 has been considered to play a critical...	3rd May, 2007	Safety Research Department, Central Research Laboratories, Kaken	Cancer Sci. 2007 Apr;98(4):541-8. Epub 2007 Mar 14. DOI Direct Link
Effects of KP-496, a novel dual antagonist for leukotriene D4 and thromboxane A2 receptors, on contractions induced by various agonists in the guinea pig trachea. BACKGROUND: A dry powder inhaler of KP-496 is currently in clinical...	4th April, 2007	Pharmacology Department, Central Research Laboratories, Kaken	Allergol Int. 2006 Dec;55(4):403-10. DOI Direct Link
KP-102 (growth hormone-releasing peptide-2) attenuates ischemia/reperfusion injury in isolated rat hearts. KP-102, a synthetic growth hormone (GH)-releasing peptide, exerts a...	29th March, 2007	Pharmacology Department, Central Research Laboratories, Kaken	Naunyn Schmiedebergs Arch Pharmacol. 2006 Aug;373(5):360-6. Epub 2006 Jun DOI Direct Link
→View more Kaken Pharmaceutical Co Limited research publications.

BioNews Results for Kaken Pharmaceutical Co Limited:
Examine the Lipitor Market Analysis and Forecasts Report, 2007-2012, 2017 and 2023	Houston Chronicle:  Jun 26 2008 2:30AM Matching: kaken pharmaceutical
Examine the Lipitor Market Analysis and Forecasts Report, 2007-2012, 2017 and 2023	Earthtimes.org:  Jun 26 2008 12:04AM Matching: kaken pharmaceutical

Kaken Pharmaceutical Co Limited Patents:
US Patent No.	Title
5350743	Bisphosphonic acid derivatives, as bone resorption inhibitors
5639915	Process for the production of aniline derivatives
5668147	Quinolinecarboxylic acid derivatives and salts thereof
5672597	Acetamide derivative
5679707	Preparation for treating wounds or hemorrhoids
→View more Kaken Pharmaceutical Co Limited patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 23 individuals from Kaken Pharmaceutical Co Limited using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 248 times since April 2007, the link to the organisation's website has been followed 0 times

Recent Search Terms used to find this page: kaken pharmaceutical co | kaken pharmaceutical co | kaken KP-496 | patent Careload | KP-496 | .

Search for more companies in Chiba

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Kaken Pharmaceutical Co Limited

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.